C

아이센스

099190KOSDAQ의료용 기기 제조업

47.0 / 100

Reference Date: 2026-04-13

Financial Score13.5 / 40
News Sentiment12.5 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is undervalued vs. peers but ROE is below the industry average. Slightly up 1.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Ai-Sensor is a company that develops, manufactures, and sells medical sensors and diagnostic equipment based on electrochemical and biosensor technologies. Its main business segments include blood glucose meters and point-of-care testing (POCT) devices. The blood glucose meter segment offers products with high accuracy and precision, while the CareSens Air continuous glucose monitoring system stands out with a competitive MARD value of 9%. The POCT segment provides a range of medical equipment, including electrolyte/gas analyzers and coagulation measurement devices.

Number of Employees

957people

Average Salary

55.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 26.524.0Point
PBR
1.68Industry Average 1.704.0Point

In line with industry avg

ROE
-1.96Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
21.41Industry Average 10.950.5Point

2.0x industry avg (risky)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲60.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -0.5% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 0Neutral 2Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position5.0Point

52w mid range (41%)

Current 19,890Won52-week high 27,00052-week low 14,750
1-month return3.0Point

1m 1.27% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral정기주주총회결과2026-03-26
  • Neutral사업보고서 (2025.12)2026-03-18
  • Neutral감사보고서제출2026-03-18